Immunotherapy for Non-small Cell Lung Cancer Patients with Cancer Cachexia
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000047035
- Lead Sponsor
- PO North East Japan Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 33
Not provided
(1) Allergy for drugs used in this study (2) Congestive heart failure, myocardial infarction, complete AV block etc, QTc longer than 470msec (3) Contraindication drug for Anamorelin (4) Double cancer (5) Other cancer treatments such as cytotoxic drug, immunotherapy, biological drug, and hormone therapy (6) Apparent interstitial lung disease (ILD) diagnosed by Chest X-ray (7) Active B hepatitis (8) Primary immunodeficiency (9) Gastrointestinal obstruction, post total gastrectomy, active bowel inflammation such asCrohn disease and ulcerative colitis (10) Sever complications (11) Steroid treatment for more than 4 weeks (12) Autoimmune disease (13) Pregnancy and its possibilities (14) Post organ implantation (15) Other inappropriate conditions judged by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall Response Rate
- Secondary Outcome Measures
Name Time Method